Home › Duchenne Muscular Dystrophy › NCT06925269

DMD Voice: Qualitative Interviews With Patients and Caregivers

Duchenne Muscular Dystrophy Quality of Life: Qualitative Interviews With Patients and Caregivers

Who can join

Ages 10 and older · Men

Inclusion Criteria:

Subsample A - Patients

Eligible participants for Subsample A must:

* Have been treated with Givinostat for at least 2 years
* Be at least 10 years of age with signed consent of a parent or legal guardian
* Be currently taking givinostat
* Willing and able to participate in a video and/or audio recorded interview

Subsample A - Caregivers

Eligible caregivers for Subsample A must:

* Be a parent or legal guardian of an individual with DMD that has been taking givinostat for at least two years
* Willing and able to participate in a video and/or audio recorded interview

Subsample B - Caregivers

Eligible caregivers for Subsample B must:

* Provide care to an individual with DMD who is unable to raise their hands above their head as confirmed by the caregiver
* Reside in the United States or Canada
* Able to read, speak, and understand English
* Willing and able to participate in a video and/or audio recorded interview Have access to a stable internet connection

Exclusion Criteria:

\-

About the study

The purpose of this study is to understand DMD functional losses or abilities and their association with independence and quality of life from the perspective of individuals with DMD and/or and their caregivers.

This is a qualitative interview study in which individuals with DMD and/or their caregivers will be asked to participate in a semi-structured, approximately 60- minute interview. Interviews will focus on functional abilities and independence. Caregivers and boys with DMD will be interviewed. This study includes no treatment nor intervention; however, some participants are being treated by a drug that is approved in the U.S. and the U.K. and under investigation in other geographies.

Sponsor: Red Nucleus Enterprise Solutions, LLC · Participants: 68 · Started: Mar 31, 2025

Contact the study team

• Mary Hubbard · Phone: 904-541-9326

Official record on ClinicalTrials.gov — NCT06925269

Locations in the U.S.

Conditions

• Duchenne Muscular Dystrophy

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.